Xeinadin acquires Wasley Chapman to strengthen North East advisory footprint
The deal brings together Wasley Chapman's century-old local presence with Xeinadin's broader resources, targeting owner-managed firms and agricultural businesses across the region.

Xeinadin, a UK-based accountancy and business advisory group, has completed the acquisition of Wasley Chapman to extend its regional coverage in the North East of England and North Yorkshire. The move follows a recent expansion of Xeinadin's London network last month and marks a strategic consolidation of resources in the Yorkshire market.
Founded in 1918, Wasley Chapman brings a long-standing history to the region, operating four offices in Whitby, Scarborough, Stokesley, and Middlesbrough. The practice has specialised in advising owner-managed companies and agricultural businesses, serving a local client base that includes numerous employers along the Yorkshire coast.
Under the terms of the acquisition, Wasley Chapman will be integrated into Xeinadin's shared operating structure. This integration aligns systems, governance frameworks, and technical resources, allowing the firm to leverage centralised infrastructure while staff continue to work from their existing offices.
The primary objective of the deal is to provide local clients with access to broader technical expertise in tax, audit, and advisory services. Xeinadin CEO Derry Crowley stated that the acquisition strengthens the firm's presence along the North Yorkshire coast and reinforces its commitment to supporting owner-managed businesses in the region.
Wasley Chapman partner Phil Cuthbert noted that the decision was driven by increasing complexity in taxation, succession planning, and regulation. He emphasised that joining Xeinadin allows the practice to advise businesses for the next generation by gaining access to additional tax specialists and technical depth.
Crucially, the acquisition is designed to preserve existing client relationships. While clients retain their familiar local contacts at Wasley Chapman, they will simultaneously benefit from the coordinated specialist support and expanded capabilities of the larger Xeinadin group.


